Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   PCE(x) 16.0224.5314.888.579.11

What is the latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH is 16.02 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202616.02
Mar202524.53
Mar202414.88
Mar20238.57
Mar20229.11

How is Price to Cash Earnings (PCE) of WINDLAS BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 16.02
-34.69
Mar2025 24.53
64.85
Mar2024 14.88
73.63
Mar2023 8.57
-5.93
Mar2022 9.11 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,740.3 Cr -0.9% 3.1% -6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.9%

3.1%

-6.5%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses